PTC Therapeutics Ends Bid to Seek FDA Approval for Rare Muscle Disease Drug

• PTC Therapeutics said it cannot resolve differences it has with the FDA in interpreting clinical trial data for Translarna, a drug it developed for Duchenne muscular dystrophy. •

Fusion Startup Raises $450 Million in Bid to Make Power Using World's Biggest Lasers

• Fusion developer Inertia has raised $450 million to build one of the world’s most powerful lasers for their fusion approach. • The post Fusion Startup Raises $450 Million in Bid

Nuclear & Fusion · February 11, 2026 (updated February 24, 2026) · 1 min · 138 words